Smith & Nephew plc
SNN NYSEHealthcare ★★★★★Latest Earnings
Date
Aug 4, 2026
ET
EPS Est.
0.94
EPS Actual
0.95
Revenue Est.
$1.64B
Revenue Actual
$3.1B
Next Earnings Report Date unconfirmed
Date
Feb 23, 2027 · Tue
Time
Time TBD
Fiscal Period
--
EPS Est.
1.21
Revenue Est.
$3.36B
Company Overview
Smith & Nephew plc (ticker SNN) is listed on NYSE with a market cap of about $12.29B. Its next earnings report is expected on Feb 23, 2027 (ET), Time TBD (date pending company confirmation), with consensus EPS of 1.21. In the last 14 reported quarters, EPS beat consensus estimates 7 times.
Actual EPS TrendRecently15Term · Jun 29, 2019 → Aug 4, 2026
Jun 29, 2019Range: -0.23 ~ 1.18Aug 4, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Aug 4, 2026 | -- | 0.94 | 0.95 | $1.64B | $3.1B |
| Mar 2, 2026 | -- | 1.16 | 1.18 | $2.77B | $3.2B |
| Aug 5, 2025 | -- | 0.79 | 0.86 | $1.53B | $2.96B |
| Feb 25, 2025 | -- | 0.92 | 0.94 | $2.96B | $2.98B |
| Oct 31, 2024 | -- | 0.80 | Below forecast↓0.50 | $1.41B | $2.83B |
| Aug 1, 2024 | -- | 0.79 | 0.75 | $2.83B | $2.83B |
| Aug 3, 2023 | -- | 0.73 | 0.70 | $2.72B | $2.73B |
| Feb 21, 2023 | -- | 0.73 | Above forecast↑0.87 | $2.6B | $2.62B |
| Jul 28, 2022 | -- | 0.76 | 0.76 | $2.62B | $2.6B |
| Feb 22, 2022 | -- | 0.87 | 0.80 | $2.62B | $2.61B |
| Jul 29, 2021 | -- | 0.79 | 0.78 | $2.65B | $2.6B |
| Feb 18, 2021 | -- | 0.92 | 1.03 | $2.53B | $1.33B |
| Jul 29, 2020 | -- | 0.29 | Below forecast↓-0.23 | $2.04B | $2.04B |
| Feb 20, 2020 | -- | 1.14 | 1.13 | $2.64B | $2.65B |
| Jun 29, 2019 | -- | -- | 0.18 | -- | $2.49B |
Original Filings (SEC)
6-K2026-08-21 ↗
6-K2026-08-19 ↗
6-K2026-08-18 ↗
6-K2026-08-14 ↗
6-K2026-08-12 ↗
6-K2026-08-12 ↗
6-K2026-08-04 ↗
6-K2026-08-04 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
